 |
3-aminopropyl-butyl phosphinic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Succinic semialdehyde dehydrogenase deficiency |
| USA Market Approval | USA |
| USA Designation Date | 2016-12-13 00:00:00 |
| Sponsor | Speragen, Inc.;13492 Research Boulevard, Suite 120-475;Austin, Texas, 78750 |
